Medical news
-
coreHEM to Support Gene Therapy Research
The WFH would like to inform readers that information in this article has been updated since its first publication. To read all updates, please see...
-
Alliance formed to better understand needs of hemostasis nurses
Nurses play a critical role on the frontline of care in the world of hemostatic and thrombotic disorders, working directly with patients, supporting them, and...
-
WFH World Bleeding Disorders Registry is here
Following the success of the World Federation of Hemophilia (WFH) World Bleeding Disorders Registry (WBDR) pilot study—and with funding confirmed—the WFH is launching the full...
-
Q&A with WFH leaders – Deon York, Lay Member, New Zealand
Over the next several months, Alain Baumann will be hosting a series of Questions & Answer sessions with World Federation of Hemophilia (WFH) leaders. Today...
-
Experts discuss latest developments at 15th MSK Congress
This May in Seoul, South Korea, the 15th WFH International Musculoskeletal Congress was held in Asia for the first time. A high-profile international event, the...
-
Unexpected cases of sporadic CJD in patients with bleeding disorders reported
Investigators have reported diagnoses of sporadic Creutzfeldt-Jakob disease (sCJD) in two patients with bleeding disorders in the United Kingdom who died in 2014. The WFH...
-
The European Haemophilia Consortium highlights Wildbad Kreuth recommendations on optimal treatment of haemophilia in Europe
In light of World Haemophilia Day, the European Haemophilia Consortium (EHC) took the opportunity to highlight an important set of 12 new consensus recommendations directed...
-
Experts evaluate options for the treatment of hemophilia in the developing world
On December 16, 2016, three experts on the treatment of hemophilia shared their experiences and recommendations during the Treatment Options for Hemophilia in the Developing...
-
Roche statement on emicizumab clinical trial adverse event
Roche has released the following statement to the WFH following the death of a patient in a clinical trial. The WFH expresses our sincere condolences...
-
A powerful new tool for advancing medical research
To advance global knowledge on diagnosis, clinical course, and treatment of bleeding disorders, data are needed that capture the entire patient experience from around the...
